Fixed‐ratio combination of basal insulin and glucagon‐like peptide‐1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge-Reference-Cited by-同舟云学术

Fixed‐ratio combination of basal insulin and glucagon‐like peptide‐1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge

Published:2020-09 Issue:S4 Volume:22 Page:24-34
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Kaneto Hideaki¹,Koshida Ryusuke²^ORCID,Baxter Mike³⁴

Affiliation:

1. Division of Diabetes, Endocrinology and Metabolism Kawasaki Medical School Kurashiki Japan

2. Medical Affairs, Sanofi Tokyo Japan

3. Medical Affairs, Sanofi Reading UK

4. Department of Diabetes and Endocrinology University of Swansea Swansea UK

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14095

Reference76 articles.

1. International Diabetes Federation. IDF Diabetes Atlas. 2019.https://www.diabetesatlas.org/en/. Accessed February 13 2020.

2. Ministry of Health Labor and Welfare. Summary results of national health and nutrition survey. 2016.https://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/kekkagaiyou_7.pdf. Accessed August 8 2016.

3. Impact of population aging on trends in diabetes prevalence: A meta‐regression analysis of 160,000 Japanese adults

4. Japan Diabetes Clinical Data Management Study Group. Fundamental statistics on diabetes in Japan. 2018.http://jddm.jp/data/index-2018.html. Accessed February 13 2020.

5. Obesity and type 2 diabetes in Japanese patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The change in Fibrosis‐4 index in Japanese patients with type 2 diabetes treated by a fixed‐ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study;Hepatology Research;2024-01-09

2. Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment;Journal of Clinical Medicine Research;2023-09

3. Distinct hypoglycemic effect of different formulations of a fixed ratio of basal insulin plus glucagon-like peptide-1 receptor agonist in a patient with pancreatic diabetes;Diabetology International;2023-04-10

4. Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial;Canadian Journal of Diabetes;2022-07

5. Charting the next century of insulin replacement with cell and gene therapies;Med;2021-10